| Primary |
| Induction Of Anaesthesia |
29.3% |
| Anaesthesia |
12.1% |
| General Anaesthesia |
12.1% |
| Product Used For Unknown Indication |
10.3% |
| Muscle Relaxant Therapy |
7.3% |
| Endotracheal Intubation |
3.9% |
| Analgesic Therapy |
3.0% |
| Antibiotic Prophylaxis |
2.6% |
| Premedication |
2.6% |
| Induction And Maintenance Of Anaesthesia |
2.2% |
| Maintenance Of Anaesthesia |
2.2% |
| Prophylaxis |
2.2% |
| Gastrectomy |
1.7% |
| Hypotonia |
1.7% |
| Resuscitation |
1.7% |
| Adenoidectomy |
1.3% |
| Neuromuscular Blocking Therapy |
1.3% |
| Arrhythmia |
0.9% |
| Cholecystectomy |
0.9% |
| Glaucoma |
0.9% |
|
| Urticaria |
10.9% |
| Circulatory Collapse |
9.1% |
| Type I Hypersensitivity |
9.1% |
| Cardiac Arrest |
5.5% |
| Dyspnoea |
5.5% |
| Neuromuscular Block Prolonged |
5.5% |
| Rash |
5.5% |
| Respiratory Arrest |
5.5% |
| Skin Test Positive |
5.5% |
| Airway Complication Of Anaesthesia |
3.6% |
| Drug Interaction |
3.6% |
| Laparoscopy |
3.6% |
| Neuromuscular Blockade |
3.6% |
| Respiratory Disorder |
3.6% |
| Shock |
3.6% |
| Surgery |
3.6% |
| Tachycardia |
3.6% |
| Type Iv Hypersensitivity Reaction |
3.6% |
| Wheezing |
3.6% |
| Anaphylactic Shock |
1.8% |
|
| Secondary |
| Anaesthesia |
29.7% |
| Drug Use For Unknown Indication |
10.4% |
| Induction Of Anaesthesia |
10.4% |
| Varicose Vein Operation |
6.3% |
| Postoperative Analgesia |
5.7% |
| Prophylaxis |
5.7% |
| Product Used For Unknown Indication |
4.7% |
| Antibiotic Prophylaxis |
4.2% |
| General Anaesthesia |
4.2% |
| Analgesic Therapy |
2.6% |
| Drug Exposure In Utero |
2.6% |
| Gastrectomy |
2.1% |
| General Anesthesia |
2.1% |
| Maintenance Of Anaesthesia |
2.1% |
| Endotracheal Intubation |
1.6% |
| Muscle Relaxant Therapy |
1.6% |
| Neuromuscular Blockade Reversal |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
1.0% |
| Shoulder Operation |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Anaphylactic Shock |
11.8% |
| Renal Failure Acute |
8.8% |
| Transaminases Increased |
8.8% |
| Hypotension |
5.9% |
| Hypoxia |
5.9% |
| Neuromuscular Block Prolonged |
5.9% |
| Rash Generalised |
5.9% |
| Shock |
5.9% |
| Tachycardia |
5.9% |
| Vomiting |
5.9% |
| Anaphylactoid Shock |
2.9% |
| Carcinoid Crisis |
2.9% |
| Cardiac Arrest |
2.9% |
| Circulatory Collapse |
2.9% |
| Drug Administration Error |
2.9% |
| Exposure During Pregnancy |
2.9% |
| Intentional Overdose |
2.9% |
| Mendelson's Syndrome |
2.9% |
| Multiple Drug Overdose Intentional |
2.9% |
| Muscle Spasms |
2.9% |
|
| Concomitant |
| Surgery |
21.9% |
| Prophylaxis |
19.4% |
| Abdominal Pain |
7.6% |
| Medical Diet |
6.9% |
| Oesophagitis |
5.5% |
| Diverticular Perforation |
5.1% |
| Hypertension |
5.1% |
| Product Used For Unknown Indication |
4.6% |
| Anaesthesia |
2.5% |
| Antibiotic Prophylaxis |
2.3% |
| Hepatic Neoplasm Malignant |
2.3% |
| Hypoalbuminaemia |
2.3% |
| Nuclear Magnetic Resonance Imaging |
2.3% |
| Induction Of Anaesthesia |
2.1% |
| Sedative Therapy |
2.1% |
| Gastritis |
1.8% |
| Abdominal Infection |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Muscle Relaxant Therapy |
1.4% |
| Pancreatic Pseudocyst |
1.4% |
|
| Abdominal Pain |
12.5% |
| Death |
9.4% |
| Disseminated Intravascular Coagulation |
9.4% |
| Hyperthermia |
9.4% |
| Pulmonary Congestion |
6.3% |
| Venous Thrombosis |
6.3% |
| Wheezing |
6.3% |
| Cardiac Arrest |
3.1% |
| Cardio-respiratory Arrest |
3.1% |
| Circulatory Collapse |
3.1% |
| Drug Eruption |
3.1% |
| Extrasystoles |
3.1% |
| Female Genital Tract Fistula |
3.1% |
| Generalised Erythema |
3.1% |
| Hepatic Enzyme Increased |
3.1% |
| Hepatotoxicity |
3.1% |
| Hyperphosphataemia |
3.1% |
| Hypertension |
3.1% |
| Hypokalaemia |
3.1% |
| Hypoxic-ischaemic Encephalopathy |
3.1% |
|
